Takeda must face US Amitiza antitrust case, judge rules
MLex Summary: Takeda Pharmaceuticals was denied a summary judgment against US antitrust claims over Amitiza. District Judge Myoung J. Joun found that plaintiffs sufficiently alleged that absent Takeda’s patent settlement with...To view the full article, register now.
Already a subscriber? Click here to view full article